Catalog Advanced Search
180 Results
-
Includes a Live Web Event on 12/11/2025 at 9:00 AM (PST)
Annual virtual symposium on topics related to healthcare-associated infections
Description:
Date: Thursday, December 11, 2025
Time: 12:00 - 4:15 pm ET / 9:00 am - 1:15 pm PT
Healthcare-associated infections (HAIs) remain a leading cause of complications in healthcare settings, posing serious risks to both patients and care providers. With one in 31 hospital patients affected by an HAI on any given day, the potential for these infections to progress to sepsis highlights the urgent need for consistent, system-wide infection prevention and control efforts.
Sepsis Alliance is proud to host the 2025 Sepsis Alliance Symposium: Healthcare-Associated Infections, a free, half-day virtual event that brings together a new lineup of expert speakers to explore the latest developments in HAI prevention, treatment, and surveillance. The event will provide healthcare professionals across disciplines with up-to-date, evidence-based insights and practical tools for reducing the burden of HAIs and preventing sepsis.
Attendees will gain valuable knowledge on emerging best practices, research, and innovations in infection prevention, with a focus on translating these insights into clinical action to improve patient outcomes.
Topics covered will include:
- Hospital Onset Bacteremia and Fungemia
- Health Disparities and HAI
- Sepsis and Surgical Site Infections
- ...and more!
The event will be offered as a free live virtual event with CME for physicians and contact hours for nurses awarded.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Demonstrate increased knowledge in building and maintaining compliant, effective infection prevention and control programs;
- Describe evidence-based infection prevention and control best practices;
- Identify innovative tools, approaches, and documentation processes to reduce HAIs in healthcare settings.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Karen Estela MPH, RN, FAPIC
Infection Preventionist
Franciscan Missionaries of Our Lady Health System
Karen D. Estela, MPH, RN, CIC, FAPIC, is a distinguished healthcare leader at the Franciscan Missionaries of Our Lady Health System, with extensive expertise in quality, clinical nursing, and health equity. Board certified in Infection Prevention and Control and a Fellow of the Association for Professionals in Infection Control and Epidemiology (APIC), Karen has made significant strides in reducing hospital-acquired infections through active surveillance, analysis, and education. She has held prominent leadership positions, including President of the APIC River Region Chapter, and serves on APIC’s Practice Guidance Committee, helping to shape standards in infection control. Karen’s work includes presenting at national conferences and publishing research, such as her study in PLoS ONE on SARS-Cov-2 B.1.1.529 infections and recent writing in Prevention Strategist about digital quality measures for hospital-onset bacteremia and fungemia. Her achievements have been recognized with honors including the 2022 Celebrate Nursing Award, the 2022 Great 100 Nurses of Louisiana Honor, and the 2025 Nightingale Award for Outstanding Community Achievement by a Nurse. Through her leadership and advocacy, Karen continues to drive improvements and promote inclusiveness in healthcare.
Katie Taylor, MD
Medical Director of Infection Prevention
Our Lady of the Lake Health
Katie V. Taylor, MD, is the Medical Director of Infection Prevention at Our Lady of the Lake Health and is an Assistant Professor of Clinical Medicine at Louisiana State University Health Sciences Center (LSUHSC). She received her BS in Biochemistry from Louisiana State University and her MD from LSU School of Medicine in New Orleans. Dr. Taylor completed her Internal Medicine residency at LSUHSC in Baton Rouge followed by Infectious Diseases fellowship at University of Florida. During medical school and residency, she was awarded for excellence in teaching by her peers. Her clinical duties include supervising LSU Infectious Diseases service at Our Lady of the Lake Health. She is the principal investigator for the research article published in PLos ONEon the clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infection. She has presented oral abstract and posters on reducing hospital-acquired infections and infectious prevention.
Darlene K. Jubah, DNP, MPH, RN, CIC, NEA-BC
Regional Manager Infection Prevention
Inspira Medical Centers Mullica Hill, Mannington &Woodbury
Darlene K. Jubah, DNP, MPH, RN, CIC, NEA-BC, is a nurse with over 20 years of healthcare experience. As of 2022, she works as the Regional Manager, Infection Prevention at Inspira Health Network in New Jersey. Previously, she worked as an Infection Preventionist at other acute care facilities in the Philadelphia and New Jersey areas. She also currently serves as the president-elect for the Association for Professionals in Infection Control and Epidemiology-APIC, Chapter 011- New Jersey.
Dr. Jubah is the owner and consultant at Keita Public Health Consulting. She offers expert advisory on healthcare, community and acute care prevention, and control practices as well as health promotion and disease prevention to community and organization leaders and executives.
Through her passion for education and coaching, Dr. Jubah serves as a part-time Clinical Adjunct Instructor. She is very passionate about empowering others through lived experiences and a shared vision of nursing empowerment and health equity.
Dr. Jubah is double board certified in Infection Control (CIC) and Nurse Executive Advanced (NEA-BC) and is a Lean Six Sigma Yellow Belt. She holds a doctorate in Nursing Practice and a Master’s in Public Health.
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 3.0 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 12/04/2025 at 11:00 AM (PST)
Content provided by Diasorin (No CE credits offered)
Webinar Description:
Join this sponsored webinar which introduces the LIAISON PLEX® Bloodstream Infection (BSI) portfolio: Smart, clinically relevant diagnostic solutions designed to close critical gaps in bloodstream infection management. Moving beyond conventional panels, this session highlights how LIAISON PLEX BSI’s split-panel design, expanded resistance gene coverage, and unique technology support timely therapeutic decisions, and antimicrobial stewardship. Discover how this platform enhances diagnostic precision, streamlines workflow integration, and drives better patient outcomes.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Diasorin for this sponsored webinar.
Sherry Dunbar, PhD, MBA
Senior Director of Scientific Affairs Programs
Diasorin
Sherry Dunbar, PhD, MBA, holds a B.S. in Microbiology and Immunology, and an MBA from the University of Maryland. She earned her Ph.D. in Medical Microbiology and Immunology from the University of South Alabama, followed by a post-doctoral fellowship in Clinical and Public Health Microbiology at Baylor College of Medicine. She previously served as the Clinical Laboratory Director at Virus Reference Laboratory in Houston, Texas.
In 1999, Dr. Dunbar joined Luminex as a Senior Scientist, where she led the Biology Research and Development group as Senior Director for eight years. Her team was instrumental in developing assay protocols, techniques, and best practices for xMAP Technology. She then served as Senior Director of Global Scientific Affairs for Luminex for eleven years.
Dr. Dunbar is currently the Senior Director of Scientific Affairs Programs at Diasorin, where she supports scientific activities related to the company’s diagnostic and research products. She has authored over fifty peer-reviewed publications and has presented numerous abstracts and seminars at scientific conferences.
-
Includes a Live Web Event on 11/18/2025 at 10:00 AM (PST)
By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Description:
Date: Tuesday, November 18, 2025
Time: 1:00 - 2:00 pm ET / 10:00 - 11:00 am PT
Building trust in vaccines requires more than sharing facts. It calls for understanding the human experiences that shape decision-making. This webinar explores the psychological, cultural, and linguistic influences that contribute to hesitancy, highlighting the role of empathy and respect in effective dialogue. Practical strategies grounded in patient-centered communication will be examined alongside collaborative models that bring healthcare teams and community partners together. By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Identify key psychological, cultural, linguistic and systemic factors that contribute to vaccine hesitancy;
- Apply patient-centered communication strategies to address misinformation and to build vaccine trust;
- Evaluate collaborative care models and cross-functional strategies that promote vaccine equity and strengthen community-level outreach efforts.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
This activity is supported by an independent medical education grant from Sanofi US (monetary support).
Sepsis Alliance gratefully acknowledges the monetary support provided for this webinar by the Sepsis Alliance Institute sponsors.
Cindy Hou, DO, MA, MBA, FACOI, FACP, FIDSA
Infection Control Officer and Medical Director of Research
Jefferson Health – New Jersey
Cindy Hou, DO, MA, MBA, CIC, CPHQ, CPPS, FACOI, FACP, FIDSA, FAPIC, is the Infection Control Officer and Medical Director of Research for Jefferson Health – New Jersey and an Infectious Diseases specialist. She has expertise in sepsis, antibiotic stewardship, infection control, patient safety, clinical quality, equity, and language access.
Dr. Hou is the Chief Medical Officer of Sepsis Alliance and a member of its Board of Directors. She earned her M.B.A. and M.A. from Boston University, a D.O. from the University of New England College of Osteopathic Medicine, and her B.S. from Yale University.
Dr. Hou is the principal investigator for an Office of Minority Health grant to reduce inequities in those with limited English proficiency. She is the co-editor of the book, “COVID-19 Viral Sepsis: Impact on Disparities, Disability, and Health Outcomes.”
Dr. Hou has a Certification in Infection Prevention and Control, is a Certified Professional in Healthcare Quality, and is a Certified Professional in Patient Safety. Dr. Hou is a Fellow of the American College of Osteopathic Internists, American College of Physicians, Infectious Diseases Society of America, and Association for Professionals in Infection Control and Epidemiology.
Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosures:
Cindy Hou disclosed the following relevant financial relationships:
- Advisory board member for Abbott
- Panelist for Sanofi
All relevant financial relationships have been mitigated.
All other individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 11/11/2025 at 11:00 AM (PST)
Content provided by Abionic (No CE credits offered).
Webinar Description:
When a patient with suspected sepsis arrives in the emergency department, every minute matters. This sponsored webinar brings together Sepsis Coordinators and frontline nurses for a candid discussion on how early detection, triage workflows, and diagnostic tools can mean the difference between recovery and rapid decline.
Moderated by Heather Orgeron, DNP, MSN, RN, Performance Improvement Supervisor, Stroke Coordinator, and Sepsis Coordinator at Ochsner Health, the panel builds on insights from the June 2025 national focus group on sepsis workflow. Speakers will explore real-world challenges, from early warning system gaps and EHR alert fatigue to the urgent need for faster, more actionable point-of-care diagnostics.
Attendees will learn practical strategies to:
- Strengthen sepsis screening and escalation protocols;
- Reduce workflow delays that cost critical time;
- Bridge the gap between clinical practice and diagnostic innovation.
Join us November 11 for this frontline conversation on how hospitals can move sepsis intervention closer to the moment of patient arrival.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Abionic for this sponsored webinar.
Heather Orgeron, DNP, MSN, RN (Moderator)
Performance Improvement Supervisor, Stroke Coordinator, Sepsis Coordinator
Ochsner Health
Heather Orgeron, DNP, MSN, RN, is the Performance Improvement Supervisor, Stroke Coordinator, and Sepsis Coordinator at Ochsner Health in Slidell, Louisiana. A dynamic nursing leader with over a decade of experience, Heather specializes in driving clinical excellence through data-driven quality improvement initiatives. Her leadership in sepsis care has led to significant improvements in emergency department outcomes at two local hospitals, including increased order set utilization and dramatic reductions in door-to-antibiotic times, enhancing timely treatment and protocol adherence. Heather is passionate about empowering nurses and fostering interdisciplinary collaboration to elevate patient care. She also serves as adjunct faculty at Southeastern Louisiana University School of Nursing, mentoring first-year students in clinical practice. A recipient of multiple nursing excellence awards, Heather continues to champion innovative strategies that improve care delivery and patient outcomes.
-
Includes a Live Web Event on 11/06/2025 at 11:00 AM (PST)
By connecting science with culture and care, this webinar underscores how equitable approaches can transform outreach into meaningful, lasting confidence in vaccination.
Description:
Date: Thursday, November 6, 2025
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Sepsis remains a critical public health concern, often stemming from common bacterial infections that can often be prevented. This informative webinar explores the essential role vaccines play in reducing the prevalence and burden of bacterial sepsis. By examining the most common bacterial causes and the science behind vaccine development, this presentation highlights how immunization strategies disrupt the pathways that lead to severe infection. Attendees will also gain insight into the rigorous processes that ensure vaccine safety and effectiveness in the fight against life-threatening illness, as well as key factors influencing vaccine confidence and hesitancy.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe why vaccines are important for preventing sepsis
- Identify the major bacterial pathogens causing sepsis
- Review principles of vaccinology, bacterial vaccine development, and safety monitoring
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
This activity is supported by an independent medical education grant from Sanofi US (monetary support).
Sepsis Alliance gratefully acknowledges the monetary support provided for this webinar by the Sepsis Alliance Institute sponsors.
Robert Donald, PhD
Retired Research Microbiologist
Robert Donald, PhD, is a research microbiologist with broad experience in bacterial, viral, and eukaryotic parasitic systems. While a senior research fellow at Merck, he contributed to drug discovery programs to identify new antibiotics to prevent S. aureus, antifungal, and parasitic infections. More recently, while a senior director at Pfizer, he led a preclinical vaccine development program targeting Klebsiella and E. coli invasive infections. Prior to this, he was also the scientific lead for preclinical programs advancing C. difficile, Enterococcus, and Group B Streptococcus vaccines, while managing supporting molecular biology and assay development teams.
Robert became motivated to assist with Sepsis Alliance’s mission due to his “firsthand” experience with the invasive bacterial pathogens that cause sepsis, and familiarity with emerging therapeutic or vaccine-based strategies currently under development in academia and biotech/pharma sectors. Now retired from commercial R&D, he seeks to contribute scientifically through advising and educating. In addition to serving on the Sepsis Alliance Advisory Board, he is consultant to Carb-X, whose mission is to fund research to develop new therapies and vaccines to address antimicrobial drug resistance.
Robert is a graduate of the University of California Santa Cruz, and did post-doctoral research at the University of California Berkeley and the University of Pennsylvania.
Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosures:
Robert Donald disclosed the following relevant financial relationship:
- Former employee, Pfizer
All relevant financial relationships have been mitigated.
All other individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 10/20/2025 at 11:00 AM (PDT)
This session explores collaborative opportunities using scenarios recently encountered by infection preventionists and clinical partners and provides insight into future opportunities as care across healthcare settings continues to be complicated and complex.
Description:
Date: Monday, October 20, 2025
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Sepsis remains a complex health issue with distinct challenges and opportunities for infection preventionists and clinical partners. Lessons learned from supply chain interruptions that impact both routine and emergency response care highlight the critical nature of collaboration across disciplines. Further, education and training supported by professional associations can help close the gap between quality outcomes and clinical needs. Held in recognition of International Infection Prevention Week (IIPW), this webinar underscores the global importance of infection prevention and the vital role of infection preventionists in improving patient safety. This session explores collaborative opportunities using scenarios recently encountered by infection preventionists and clinical partners and provides insight into future opportunities as care across healthcare settings continues to be complicated and complex.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Review a collaborative framework that can be used by infection preventionists and clinicians in their joint efforts to identify, respond, and prevent infection and sepsis;
- Analyze case studies illustrating successful collaborative approaches to infection and sepsis prevention;
- Identify specific activities that professional associations can take to support these prevention efforts.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
Sepsis Alliance gratefully recognizes the support provided for this webinar by the Sepsis Alliance Institute sponsors.
Ruth Carrico, PhD, DNP, FNP-C, CIC, FSHEA, FNAP, FAAN
Senior Partner; Professor, Adjunct
Carrico & Ramirez, PLLC; University of Louisville School of Medicine, Division of Infectious Diseases
Ruth Carrico, PhD, DNP, APRN, FNP-C, CIC, FSHEA, FNAP, FAAN, is a senior consultant with Carrico & Ramirez, PLLC focused on infectious diseases, infection prevention and control, and vaccinology. She is also a Family Nurse Practitioner based in Louisville, Kentucky. In addition, Dr. Carrico is a Professor, adjunct faculty, with the University of Louisville School of Medicine, Division of Infectious Diseases. Dr. Carrico has received training specific for healthcare epidemiology at the Centers for Disease Control and Prevention (CDC) in conjunction with the Rollins School of Public Health at Emory University in Atlanta and the Society for Healthcare Epidemiology of America (SHEA).
Dr. Carrico has worked in the field of infectious diseases and infection control for more than thirty years. Her work in infection control began in 1994 when she assumed the position as Director of the Infection Control department at the University of Louisville Hospital. She quickly recognized this as an area of intense interest and began active collaboration, seeking mentoring from national and international experts. From 2005-2012, she served as Editor for the APIC Text of Infection Control and Epidemiology, was appointed to the National Biosurveillance Subcommittee (NBS) Advisory Committee to the Director, Centers for Disease Control and Prevention, and in 2010 became a SHEA Fellow. In 2011, Dr. Carrico was appointed by Secretary Sebelius (Health and Human Services), to the Healthcare Infection Control Practices Advisory Committee (HICPAC). In 2012, she was presented with the Carole DeMille Achievement Award by APIC, an honor for an Infection Preventionist. In 2013, Dr. Carrico began serving the National Foundation for Infectious Diseases as the Board’s Nurse Planner and in 2014 became a Robert Wood Johnson Foundation Executive Nurse Fellow alumna.
Dr. Carrico served as the 2016 President of the Certification Board of Infection Control and Epidemiology, Inc. (CBIC). In 2018, Dr. Carrico assumed the position of President of the Kentucky Nurses Association and in 2020 was recognized as a Distinguished Fellow in the National Academies of Practice. In October 2021, Dr. Carrico was inducted as a Fellow in the American Academy of Nursing, the highest honor in the nursing profession. Also in October 2021, Dr. Carrico assumed the role of Executive Director, then Senior Scientific Officer of the Norton Infectious Diseases Institute (NIDI) at Norton Healthcare in Louisville, Kentucky, where she supported the scientific and educational activities of the four Centers (Clinical Research, Education & Training, Global Health, Public Health) within the Institute until early 2023. During that time, she also led the CDC-funded Kentucky Infection Prevention (KYIP) Training Center, a broad educational program for infection preventionists and partners across the healthcare continuum. Following successful launch of the NIDI Centers and the KYIP Training Center, in 2023 Dr. Carrico moved to work as a full-time consultant with healthcare organizations, public health workers, providers, and industry partners sharing interests in addressing the challenges of infectious diseases prevention. Dr. Carrico serves on numerous advisory boards focused on vaccines and improving vaccination rates. She continues to conceptualize and implement novel immunization approaches including training and competence development for healthcare providers and healthcare workers, including an educational website supporting vaccination and international travel health (TH101.com). Dr. Carrico provides consultation and service as Medical Affairs lead for VaxCare, LLC [Orlando] and maintains a clinical practice focused on vaccines, vaccination, and immunization processes (Trifecta Medical Group, Louisville, KY).
Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
Financial Relationship Disclosures:
All individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Includes a Live Web Event on 10/14/2025 at 12:00 PM (PDT)
Content provided by Vantive (No CE credits offered)
Webinar Description:
Join Vantive for an in-depth exploration of the TIGRIS trial. Jonathan Eaton, MD, will walk attendees through a patient journey, exploring the challenges of managing patients with endotoxic septic shock, emerging therapies, and how Dr. Eaton’s involvement in the TIGRIS trial has impacted his bedside practice. You do not want to miss this sponsored webinar on one of today’s hottest topics in the management of sepsis.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Vantive for this sponsored webinar.
Jonathan Eaton, MD
Title: Assistant Professor of Internal Medicine; Program Director of Critical Care Medicine Fellowship; Assistant Director of Extracorporeal Life Support Program; Director of ECMO Transport
LSU Health Shreveport
Jonathan Eaton, MD, serves as a Critical Care Specialist at LSU Health Shreveport, where he contributes to the Extracorporeal Life Support Program, extracorporeal membrane oxygenation (ECMO), continuous renal replacement therapies (CRRT), plasma exchange, and sepsis management.
Dr. Eaton received his medical degree from the American University of the Caribbean and completed his Internal Medicine training at LSU Health Shreveport. He completed his fellowship training in Critical Care Medicine at LSU Health Shreveport.
-
Annual, virtual conference covering sepsis-related topics and offering RN CE Contact Hours
Description
Sepsis Alliance Summit returns for a 6th year this September! This free, virtual 2-day conference features insightful, innovative presentations from a diverse group of experts, including clinicians, researchers, innovators, and key leaders in the field.
FREE CE Credits Offered!
CME and continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Conference Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:
Agenda
September 24, 2025
Time (ET) Session Title Presenter 10:00-10:15 Opening Remarks Carl Flatley
Founder, Sepsis Alliance
Theresa M. Mostasisa, EdD, PHN, DSD, MS, BSN, RN Quality Nurse Consultant, Sepsis Coordinator, Kaiser Permanente Redwood City Medical Center10:15-10:45 Wife and Death: A Lady Glaucomflecken Keynote Kristin Flanary, MA
aka 'Lady Glaucomflecken'
International Speaker, Podcaster, Glaucomflecken10:50-11:20 New Developments in Sepsis Quality Measurement Raymund Dantes, MD, MPH
Associate Professor of Medicine, Emory Healthcare
Kristina Betz, MD, PhD
Lead of the Measure Development and Validation Unit for Surveillance Branch/National Healthcare Safety Network (NHSN), Division of Healthcare Quality Promotion at CDC11:25-11:55 Baxter Sponsored Session: Fluids, Sepsis, and Mortality: Past, Present, and Future Angela Craig, MS, APN, CCNS, CCRN
Medical Science Liaison - Medical Affairs, Baxter
Lisa M Soltis, MSN, APRN, PCCN, CCRN-CSC-CMC, CES-A, CCNS, FCNS, FCCM,
Sr. ECMO Clinical Support Specialist, Heart and Lung Division, Fresenius Medical Care11:55-12:10 Break 12:10-1:15 Before and After Sepsis: Opportunities for Change David Carlbom, MD
Associate Professor of Medicine, Pulmonary Critical Care & Sleep Medicine,
University of Washington School of Medicine
Fatima Sheikh, MSc, PhD(c)
PhD Candidate in the Health Research Methodology Program,
McMaster University
Hailey Bain
Sepsis Survivor, Patient Partner,
Sepsis Canada
Catherine Hough, MD, MSc
Professor and Chair of the Department of Medicine
Oregon Health & Science University
Kristina Rudd, MD, MPH
Assistant Professor in the Department of Critical Care Medicine
University of Pittsburgh
Stephanie Parks Taylor, MD, MS
Professor of Medicine, Department of Internal Medicine,
University of Michigan
John Boyd, MD
Intensivist and Investigator at the Institute for Heart + Lung Health
Providence Hearth and Lung Institute at St. Paul’s Hospital1:20-1:35 AHA Living Learning Network: Sepsis Champions Leadership Series Kavita Bhat, MD, MPH, CPHQ
Senior Program Manager, AHA Funded Partnerships, American Hospital Association1:40-1:55 Examining the Hospital Burden of Sepsis in the United States Pamela Owens, PhD
Director of the Division for Healthcare Data and Analytics in the Center for Quality Improvement and Patient Safety (CQuIPS), Agency for Healthcare Research and Quality (AHRQ)2:00-2:30 Diasorin Molecular Sponsored Session: Unmasking the Silent Threat: Rapid Molecular Diagnostics for Fungal Sepsis and Detection of Candida auris Siu Kei (Jacky) Chow, Ph.D., D(ABMM)
Clinical Laboratory Director, Multicare Health System, Washington State2:30-2:45 Break 2:45-3:30 Strengthening Documentation to Drive SEP-1 Compliance and Quality Performance (CE Session) Alexis Wells, MSN, RN, CCDS, LSSYB
Associate Director of Education and Quality,
Emory Healthcare
Stacia Gandee, RHIA, CCS, CDIP, LSSYB
Manager of Clinical Documentation Integrity, JPS Health Network3:35-4:05 Trials and Triumphs from 20 Years of 'Slay Sepsis' at Santa Barbara Cottage Hospital (CE Session) Natalie Achamallah, MD, MA, MS, FCCP
Director of Critical Care Education for Internal Medicine Residency, Santa Barbara Cottage Hospital4:10-4:20 Roche Sponsored Session: Sepsis Detection in Acute Care: How Biomarkers and AI Assist in Diagnosis and Prediction of Adverse Outcomes Robin Carver, RN, MSN, CIC
Vice President, Health System Management, Prenosis, Inc.4:25-4:55 Novartis Sponsored Session: Which Symptoms and Impacts Matter to Patients Who Suffered Sepsis-Associated Acute Kidney Injury? Preliminary Results from a Patient Experience Study Simon Messner, PhD
Director, Patient Engagement Scientific Excellence, Novartis5:00-5:30 Breaking the Cycle: Managing Sepsis Recovery and Preventing Readmissions (CE Session) Philip Nicotera, MHA, PA-C
Sepsis Program Manager, Lee Health
Scott Liebal, BSN, CCRN
Advanced Application Analyst, Medical Informatics, Lee Health5:35-5:50 Closing Remarks Myrna Pair
Sepsis Survivor and AdvocateSeptember 25, 2025
Time (ET) Session Title Presenter 10:00-10:15 Opening Remarks Ronnie 'The King' Coleman
Former Mr. Olympia and Professional Bodybuilder; Sepsis Survivor and Advocate10:15-10:45 Keynote: Pediatric Sepsis from the Perspective of "The Pitt" Sylvia Owusu-Ansah, MD, MPH. FAAP
Associate Professor of Pediatrics and Emergency Medicine; Associate Vice Chair of Diversity, Equity, and Inclusion Department of Pediatrics, University of Pittsburgh School of Medicine10:50-11:20 Previously Healthy Patients with Sepsis: Shedding Light on a Unique Cohort and Opportunities for Enhanced Care Rachel K. Hechtman, MD
Clinical Lecturer, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine
University of Michigan11:25-11:55 Abionic Sponsored Session: Pancreatic Stone Protein: Early and Rapid Sepsis Detection Across Patient Pathways Andrew Shorr, MD, MBA
Section Director, Pulmonary and Critical Care Medicine, Medstar Washington Hospital Center (MWHC)
Evangelos J. Giamarellos-Bourboulis, MD, PhD
Professor of Internal Medicine and Infectious Diseases, Medical School of the National and Kapodistrian University of Athens
Patrick Pestalozzi, MBA
Chief Executive Officer, Abionic11:55-12:10 Break 12:10-12:40 The Paradigm Shift in Diagnostics to Support Earlier Diagnosis of Sepsis and Antibiotic Stewardship in the Emergency Department (CE Session) Larissa May, MD, MSPH, MBA
Professor of Emergency Medicine, University of California Davis12:45-1:15 Hospital-Acquired Sepsis: The Hidden Challenge in Patient Safety (CE Session) Namita Jayaprakash, MB BcH BAO, MRCEM
Associate Medical Director - Quality and Safety, Emergency Medicine Physician Lead - Henry Ford Health Sepsis Program, Henry Ford Health1:20-1:35 Diasorin Immunodiagnostics Sponsored Session: Rapid Clarity in the ED: Tackling Diagnostic Uncertainty in Suspected Sepsis David B. Hale, MD, PhD
Director of Emergency Medicine, Associate Chief Medical Officer, and ED Sepsis Champion, ThedaCare New London Hospital1:40-1:55 Flosonics Medical Sonsored Session: What SEP-1 Misses and How Smart Teams Fill the Gaps Jaclyn Bond, MSN-LM, MBA-HM, RN
Former Director of Nursing1:55-2:10 Break 2:10-2:35 Sepsis Subphenotypes: Development, Validation, and Implementation of a Precision Medicine Approach (CE Session) Sivasubramanium (Siva) Bhavani, MD, MS
Assistant Professor of Medicine, Emory School of Medicine2:40-3:10 "Now What?”: Confronting the Chaos After Sepsis Bundle Completion (CE Session) Sarah Vance MSN, RN, CCRN
Critical Care Nurse Educator, Consultant, Speaker, Writer, ISeeUNurse, LLC3:15-3:45 Boston Scientific Sponsored Session: Treating Kidney Stone Patients with Higher Risk for Sepsis Khurshid Ghani, M B ChB, MS, FRCS
Clinical Professor of Urology, University of Michigan3:50-4:25 Sepsis: Advancing Care Through Unique Partnerships and Collaboration (CE Session) Pat Posa RN, BSN, MSA, CCRN-K, FAAN
Quality and Patient Safety Program Manager, UH/CVC, Michigan Medicine
Hallie Prescott, MD, MSc
Associate Professor of Internal Medicine, Division of Pulmonary Critical Care, University of Michigan
Amy Milewski, MD, MBA
Vice President and Associate CMO, Clinical Partnerships, Blue Cross Blue Shield of Michigan
Scott Flanders, MD
Chief Clinical Strategy Officer, Michigan Medicine4:30-4:35 Closing Remarks Accreditation Statements
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 10.1 contact hours.
Other healthcare professionals will receive a certificate of attendance for 8.25 contact hours.
Financial Relationship Disclosures:
Larissa May disclosed the following financial relationships:
- Consultant, Cytovale
- Ad board member, Shiniogi
- Advisor, Speaker, bioMérieux
- Advisor, speaker, ThermoFisher
- Speaker, Inflammatix
- Advisor, Roche/Genmark
All relevant financial relationships have been mitigated.
All other individuals in control of content disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Content provided by Beckman Coulter (No CE credits offered)
Webinar Description:
This sponsored presentation will highlight the crucial role of host response in infection and sepsis management for improved patient outcomes. We will explore the clinical utility of novel biomarkers like MeMed BV (bacterial/viral differentiation) and MDW (early sepsis detection) and discuss strategies to integrate these innovations into routine practice, enhancing diagnostic precision and optimizing care.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Beckman Coulter for this sponsored webinar.
Richard Hamilton, MD, MBA, FAAEM, FACEP, FACMT
Professor and Chair, Emergency Medicine
Drexel University College of Medicine
Richard Hamilton, MD, MBA, FAAEM, FACEP, FACMT, is Professor and Chair, Emergency Medicine, Drexel University College of Medicine. He is the Executive Medical Director of Pediatric Emergency Medicine at St Christopher's Hospital for Children. He was formerly the Regional Associate Dean for the Crozer Keystone Campus and EM System Chair of the Crozer Keystone Health System. He is a graduate of the University of Pennsylvania and Hahnemann University College of Medicine. Dr. Hamilton trained at the San Diego Naval Hospital and the Naval Aerospace Medical Institute, completed an EM Residency at the Bronx Municipal Hospital Center / Albert Einstein, and did his Toxicology Fellowship at New York City Poison Control Center / NYU Bellevue.
Dr. Hamilton's research interests include PFAS toxicity, Manganese, water quality, synthetic cannabinoids, MRSA, pharmacology, toxicology, applying game theory to medicine, aerospace medicine, and commercial space travel. He has received awards for his teaching and research and is a widely published author of manuscripts, textbooks, book chapters, and patents.
Dr. Hamilton is a former EM Program Director and has been EM Chair at Drexel University since 2006. He edited the Tarascon Adult Emergency Pocketbook and Tarascon Pocket Pharmacopeia, which was sold in 17 countries and has been translated into Spanish and Japanese. Dr. Hamilton is a Fellow of the American Academy of Emergency Medicine, the American College of Medical Toxicology, the American College of Emergency Physicians, and an Associate Fellow of the Aerospace Medical Association. He is the Past President of the Association of Academic Chairs in Emergency Medicine and the Pennsylvania College of Emergency Physicians. Dr. Hamilton blogs at www.emtoxcast.com and www.thetoxfiles.com.
Peter S. Antkowiak, MD
Vice Chair of Clinical Operations, Department of Emergency Medicine
UMass Medical School - Baystate Health
Dr. Peter Antkowiak is the Vice Chair of Clinical Operations in the Department of Emergency Medicine at Baystate Health. In this role, he oversees a network of five emergency departments that care for over 220,000 patients annually, including Baystate Medical Center, an academic Level 1 Trauma Center with one of the busiest EDs on the east coast and a dedicated pediatric ED. He is the director of the EM Operations & Administrative Fellowship at Baystate. His primary research interests include ED throughput optimization, applications of novel diagnostics and AI in EM, and understanding physician resource-utilization. He also serves as an expert medical consultant for biotech and healthcare AI startups.
Prior to this role, Dr. Antkowiak was Chief of Emergency Medicine at UMass Harrington Healthcare, overseeing two EDs with a combined 40,000+ patient visits per year staffed by Harvard Medical Faculty Physicians. During his five-year tenure as Chief, Dr. Antkowiak recruited and led a team of physicians that significantly enhanced quality and operational metrics while concurrently optimizing practice revenues. Dr. Antkowiak was responsible for developing long-term strategy, managing the practice budget, and led all clinical operations including overseeing physician directors in Ultrasound, Education, EMS, Operations, and Quality/Patient Safety.
Dr. Antkowiak was previously an academic faculty member at Beth Israel Deaconess Medical Center and an instructor at Harvard Medical School. He chaired the Harvard Medical Faculty Physicians EM Program & Faculty Development committee, and led several network initiatives focused on faculty retention, scheduling principles, and community to tertiary care patient transfer processes.
Dr. Antkowiak studied neuroscience and economics at McGill University, he then earned an MD from Albany Medical College. After residency at Maine Medical Center/Tufts University School of Medicine, he completed a fellowship in ED Operations & Administration and an MPH in Healthcare Management & Policy at the Harvard University T.H. Chan School of Public Health.
Melissa Naiman, PhD, EMT-B
Medical Director for Sepsis & Host Response
Beckman Coulter
Melissa Naiman, PhD, EMT-B, is a Medical Director for Beckman Coulter Diagnostics. She trained in chemistry and has a PhD in Public Health with a research interest in technology adoption in healthcare settings. She spent her early career in an academic research center at the University of Illinois that developed medical devices and diagnostics, including identifying novel biomarkers for military health applications. Today she focuses on accelerating innovation in host response-based diagnostic strategies targeting acute infection and sepsis management.
-
Recorded On: 08/26/2025
This webinar explores the groundbreaking international effort to develop a burn-specific framework for early identification, prevention, and management of sepsis.
Description:
Date: August 26, 2025
Time: 2:00 - 3:00 pm ET
Burn-related sepsis presents unique diagnostic and treatment challenges that traditional sepsis protocols fail to address. This webinar explores the groundbreaking international effort to develop a burn-specific framework for early identification, prevention, and management of sepsis. Drawing from expert consensus and the latest evidence, the webinar highlights key distinctions in pathophysiology, the limitations of conventional screening tools, and the development of actionable clinical recommendations designed to improve outcomes in this high-risk population.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Differentiate between the systemic inflammatory response caused by burn injury and true sepsis, using current definitions and diagnostic criteria;
- Identify clinical indicators and evidence-based triggers for initiating sepsis management in burn patients;
- Apply the Surviving Sepsis After Burn Campaign (SSABC) recommendations to guide prevention, diagnosis, and treatment strategies in clinical practice;
- Describe existing protocols for burn sepsis management and identify opportunities for improvement based on SSABC consensus guidelines.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors.
David Greenhalgh, MD, FACS
Professor Emeritus
University of California Davis
David G. Greenhalgh, MD, FACS, was named Chief of Staff for Burn Surgery at the Shriners Hospitals for Children Northern California, and Department of Surgery for the University of California, Davis, School of Medicine in 1997. He retired from the University of California, Davis in 2022 as Professor Emeritus and then retired from Shriners in 2024.
Upon completion of his fellowships in 1989, Dr. Greenhalgh was employed at Shriners Hospitals for Children Cincinnati and the University of Cincinatti. From 2006-2007, Dr. Greenhalgh served as President of the American Burn Association and was President of the International Society for Burn Injuries from 2020-2022. He is past Editor of Burns Open and remains Associate Editor for Journal Burn Care and Research and PLOS.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- Differentiate between the systemic inflammatory response caused by burn injury and true sepsis, using current definitions and diagnostic criteria;